Immunovia ABIMMVF -61.59%44 Days Inventory is 94.29 as of Mar. 2026, which is 48% below its 10-year median of 180.55. GuruFocus rates IMMVF with a GF Score™ of 44/100 and a GF Value™ of $0.01. The stock has 4 warning signs investors should review. Among 177 Medical Diagnostics & Research companies, Immunovia AB ranks worse than 84.18% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Immunovia AB's Average Total Inventories for the
three
months ended in Mar. 2026 was $0.02 Mil. Immunovia AB's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $0.02 Mil.
Hence, Immunovia AB's Days Inventory for the
three
months ended in Mar. 2026 was 94.29.
The historical rank and industry rank for Immunovia AB's Days Inventory or its related term are showing as below:
IMMVF'
s Days Inventory Range Over the Past 10 Years
Min: 110.12 Med: 180.55 Max: 319.38
Current: 204.09
During the past 13 years, Immunovia AB's highest Days Inventory was 319.38. The lowest was 110.12. And the median was 180.55.
IMMVF's Days Inventory is ranked worse than 84.18% of 177
companies
in the Medical Diagnostics & Research industry
Industry Median: 70.8
vs IMMVF: 204.09
Immunovia AB's Days Inventory
increased
from Mar. 2025 (0.00) to Mar. 2026 (94.29).
It might indicate that Immunovia AB's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Immunovia AB's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.97.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Immunovia AB's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.39.
Immunovia AB (OTCPK:IMMVF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Immunovia AB's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Immunovia AB's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Immunovia AB Days Inventory Related Terms
Immunovia AB Days Inventory Historical Data
* Premium members only.
The historical data trend for Immunovia AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IMMVF vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Immunovia AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Immunovia AB Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Immunovia AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where Immunovia AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Immunovia AB (IMMVF) has a Days Inventory of 94.29 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Immunovia AB and its competitors. This is 48% below median its historical median of 180.55. Over the past decade, Immunovia AB's Days Inventory has ranged from 110.12 to 319.38. According to the industry distribution chart, Immunovia AB ranks #149 out of 177 companies in the Medical Diagnostics & Research industry, placing it in the top 84.2%.
Is Immunovia AB's Days Inventory too high?
Immunovia AB's current Days Inventory of 94.29 is 48% below median its 10-year median of 180.55. Over the past 10 years, this metric has ranged from a low of 110.12 to a high of 319.38. The Medical Diagnostics & Research industry median Days Inventory is 70.80. Immunovia AB's value of 94.29 is 33.2% above this industry median. Based on the distribution chart, Immunovia AB ranks #149 out of 177 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Immunovia AB has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Immunovia AB's Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Immunovia AB ranks #149 out of 177 companies for Days Inventory. This places Immunovia AB in the lower half of its industry. The industry median Days Inventory is 70.80. Immunovia AB's value of 94.29 is 33.2% above this benchmark. Historically, Immunovia AB's own Days Inventory has ranged from 110.12 to 319.38 over the past decade. While the company's 10-year median is 180.55 vs. the industry median of 70.80, Immunovia AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 70.80, based on 177 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Immunovia AB's current Days Inventory of 94.29 is 33.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Immunovia AB and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 70.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Immunovia AB's current Days Inventory is 94.29, which is 48% below median its own 10-year median of 180.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Immunovia AB stock overvalued right now?
Immunovia AB (IMMVF) has a current Days Inventory of 94.29. The stock's GF Value™ is $0.01, compared to a current price of $0.02 — trading 100% above its estimated fair value. The current Days Inventory is 94.29, which is 48% below median its 10-year median of 180.55 and 33.2% above the Medical Diagnostics & Research industry median of 70.80. Immunovia AB's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Immunovia AB (IMMVF), the current Days Inventory is 94.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Immunovia AB (IMMVF) Overvalued in 2026?
Based on GuruFocus' analysis, Immunovia AB stock appears to be overvalued.
The current stock price of $0.02 is trading 100% above its estimated GF Value™ of $0.01.
Key valuation signals for IMMVF:
Days Inventory: 94.29 (48% below median its 10-year median of 180.55)
GF Value™: $0.01 vs. price of $0.02 (100% above fair value)
Industry Position: 33.2% above the Medical Diagnostics & Research median (#149 of 177)
No single metric tells the full story. See the IMMVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Immunovia AB is a diagnostic company. The company develops and commercializes diagnostic tools to detect proteins and autoimmune diseases. The company is developing its next-generation blood test to detect pancreatic cancer in high-risk individuals. IMMray platform is dedicated to the early detection of pancreatic cancer. Its technology platform IMMray (TM), is based on antibody microarray analysis.
44GF Score
Get the complete analysis for IMMVF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IMMVF has been successfully added to your 
